CPhI China Scheduled for Shanghai
CPhI China and co-located events bring together suppliers of raw materials, ingredients, packaging solutions, machinery, and manufacturing.
CPhI China, hosted by UBM EMEA and CCCMHPIE and co-organized by UBM Sinoexpo, returns to the Shanghai New International Exhibition Centre, SNIEC, China from June 24–26, 2015. The event, which marks a decade in partnership with P-MEC China, is co-located with ICSE, BioPh, Innopack, LABWorld, Fi Asia China, and Hi China.
The event brings together suppliers of raw materials, ingredients, packaging solutions, machinery, and manufacturing and more than 30,000 visitors.
Fi Asia-China and Hi China will represent the food ingredients market; the show also features natural extracts, logistics, finished formulation, environmental protection, and clean tech zones.
CPhI & P-MEC China features 140,000 square meters of exhibit space, accommodating more than 2,800 exhibitors from 100 countries. The event also hosts more than 80 conferences, summits, and seminars during the three-day event, including the 6th China World CEO Summit; 2015 Pharmaceutical R&D innovation and Outsourcing Management Conversation; and 2nd BioPh China Summit 2015.
Source: CPhI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
